Pfizer announced that it is proceeding with multiple ascending doses after completing single ascending dose dosing in a phase 1 study in healthy adults to evaluate the safety and tolerability of a new oral therapeutic antiviral for SARS-CoV-2, the virus that causes COVID-19. Read the full article… Date: 03.2021 Source: pharmastar.co.uk
Pfizer begins clinical trials of an oral antiviral for COVID-19. Read More »
The pandemic revolutionized the doctor-patient relationship. So many challenges in recent months have gone beyond the clinical aspect and have largely invested the ethical sphere, such as resource scarcity. Read the full article… Date: 03.2021 Source: pharmastar.co.uk
Covid-19: effects of the pandemic on the national health care system Read More »
Overall, issues regarding drugs are significantly reduced and reflect updates periodically communicated by AIFA, however, the Network is continuing to pick up signs of issues regarding mainly #medicaldevices. Read the full article… Date: 05.2021 Source: pharmastar.co.uk
Best practices of hospital pharmacists and health care companies for Covid Phase 2 Read More »
